Background -Atopic dermatitis is associated with skin barrier defects. In people, noninvasive techniques are used to quantify the skin barrier functionality. In dogs, transepidermal water loss (TEWL), stratum corneum hydration and pH have been used to assess skin barrier function. However, few studies have determined their repeatability.Objective -To assess the repeatability of measurements of skin hydration, TEWL, pH, skin absorbance and erythema in healthy and atopic dogs. Animals -Fifteen healthy and 15 atopic privately owned dogs.Methods and material -Three repeated measurements using Corneometerâ, Skin-pH-Meterâ, Colorimeterâ and VapoMeterâ were obtained from inguinal, axilla, pinna and interdigital space by three investigators. Intraand interobserver variability (coefficient of variation, correlation coefficients and intraclass correlation coefficients) and difference between the two groups (t-test or Mann-Whitney U-test) were determined.Results -High repeatability and low variation were observed both intra-and interobservers for all devices except the VapoMeterâ. The most repeatable device was the Skin-pH-Meterâ, whereas the VapoMeterâ was the device with the highest intra-and interobserver variability. Atopic dogs had a significantly increased pH (inguinal P = 0.03; axilla P = 0.02) and erythema (inguinal P = 0.01; axilla P = 0.02) compared to healthy dogs. No differences between the two groups were detected using the Corneometerâ, VapoMeterâ or Colorimeterâ (tartrazine absorption). Conclusion and clinical significance -The results of this pilot study support the use of Corneometerâ, Skin-pH-Meterâ and Colorimeterâ in the assessment of skin barrier function in dogs; further investigations to optimize measurements and confirm these results are needed.
Background Neisseria spp. is a common inhabitant of the oral flora of cats and dogs; it is a potential cause of cutaneous infections in people secondary to animal bites. Neisseria dumasiana is a new species identified in the oral cavity of dogs. It has not been linked to cutaneous infections in people. Objective To describe the clinical and microbiological features of Neisseria dumasiana isolated from the skin of a dog. Animal A 3‐year‐old male neutered mixed breed dog from Florida, USA. Methods and materials The dog had no travel history within or outside the United States; the dog was presented with draining tracts on the dorsum. Five months before the initial examination the dog was involved in a fight with another dog. Results An aerobic bacterial culture was performed and isolated multiple small, grey, moist, circular, convex and nonhaemolytic colonies. A Gram stain showed Gram‐negative coccobacilli present in pairs. The bacteria were oxidase‐ and catalase‐positive and negative for indole and fermentation of fructose, xylose, sucrose, mannitol and sorbitol. Polymerase chain reaction, using 16S rDNA sequencing, was positive for Neisseria dumasiana. Clinical and microbiological resolution occurred within three months of treatment. Conclusions and clinical importance To the best of the authors’ knowledge, this is the first report of a deep cutaneous dermatitis associated with Neisseria dumasiana in a dog. This case should stimulate veterinary clinicians and microbiologists to consider Neisseria spp. among the differential diagnoses of nonhealing wounds in dogs, particularly those associated with bite wounds.
Background Vascular endothelial growth factor (VEGF) is a cytokine involved primarily in angiogenesis. In human atopic dermatitis (AD), VEGF has been detected in the stratum corneum and blood. Objective To evaluate VEGF‐A expression in the serum and stratum corneum of healthy and atopic dogs, and its possible correlation with disease severity in atopic dogs. Animal Fifteen atopic and 15 healthy, privately owned dogs. Methods and materials The severity of clinical signs associated with AD was evaluated with the Canine Atopic Dermatitis Extent and Severity Index (CADESI‐04). For all dogs, a single blood sample was performed and serum collected. Tape stripping (15 times) was performed on the left periocular area (lesional skin). A commercially available canine‐specific VEGF‐A enzyme‐linked immunosorbent assay was performed with all samples. Results Vascular endothelial growth factor‐A was undetectable in the serum. In the stratum corneum, there was no significant difference in VEGF‐A concentrations between healthy (mean 89.4 ± 59.5 pg/ml) and atopic dogs (mean 100.3 ± 77.1pg/ml) (P = 0.71). There was no correlation between stratum corneum VEGF‐A concentrations and CADESI‐04 scores. Conclusions and clinical importance The role of VEGF in canine AD is unclear. Because of many variants, VEGF‐C and VEGF‐D or VEGF‐A isotopes should be explored in the skin to better evaluate the role of VEGF in canine atopy. Full‐thickness skin biopsy, molecular biology and histopathological investigation may be necessary to further assess cutaneous VEGF expression.
SummaryTwo six-year-old macho alpacas from southeastern Alabama were presented to our Large Animal Teaching Hospital for a two-week history of pruritic, ulcerative skin lesions around the eyes, hind legs and groin. Histopathology, bacterial culture and fungal culture revealed Candida species with secondary Staphylococcus aureus pyoderma. Blood zinc levels for both alpacas were considered to be below laboratory reference values. Both alpacas were treated with topical antiseptic, antibiotic and antifungal therapy along with systemic therapy using injectable ceftiofur, and dietary zinc supplementation was initiated. Ulcerative skin lesions resolved following about four weeks of antimicrobial therapy. Scaling and crusting lesions resolved after about six weeks of dietary zinc supplementation. At 180 days after presentation, both alpacas were doing well with no new lesions. This is the first case report of successfully treated cutaneous candidiasis in the alpaca.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.